Hollings Renton
Director · ANAPTYSBIO, INC
IndividualSelling only6 10b5-1 trades
- 2024
- Oct 2, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hollings Renton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Faga - $2.14M in ANAB purchases and sales in the last 12 months
- John P. Schmid - $1.16M in ANAB purchases and sales in the last 12 months
- Eric J. Loumeau - $1.08M in ANAB purchases and sales in the last 12 months
- Magda Marquet - $531K in ANAB purchases and sales in the last 12 months
- Paul F. Lizzul - $264K in ANAB purchases and sales in the last 12 months
- Dennis Mulroy - $199K in ANAB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hollings Renton?
Hollings Renton is a corporate insider, tracked as Director of ANAPTYSBIO, INC (ANAB). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Hollings Renton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Hollings Renton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($1.27M) across all tracked filings.
